Labiotech.eu

Expert Advice 5 Oct 2021

How to Choose the Right Headquarters for Your Biotech Startup

Choosing where to plant your biotech company’s roots is a fundamental question driven by access to capital, talent, and infrastructure. But the pandemic is accelerating a decentralization movement, changing the way companies think about headquarters. Regions like the Bay Area and Boston in the US, or the UK’s golden triangle remain huge draws for biotech […]

October 5, 2021 - 6 minutesmins - By Mark Zipkin

News and Trends 4 Oct 2021

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

Although most gene therapy still relies on non-infectious viral vectors for delivery, a recent venture financing round for the Swiss company Anjarium Biosciences has shone the spotlight on alternative vectors, including lipid nanoparticles and electric pulses. Last month, Anjarium Biosciences raised €51M (CHF55.5M) in a Series A financing round to advance its gene delivery system […]

October 4, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 1 Oct 2021

Novo Nordisk Foundation Pumps €85M into Carbon Capture Research

As pressure mounts to tackle climate change, the Danish Novo Nordisk Foundation has granted €84.7M to the world’s first research institution dedicated to capturing carbon dioxide from the air and harnessing the gas as a raw material. The new Novo Nordisk Foundation CO2 Research Center has the mission to efficiently capture, store, and recycle the […]

October 1, 2021 - 6 minutesmins - By Anita Chakraverty

artificial intelligence, AI, computer-aided drug design, drug discovery

Artificial Intelligence: A Road to Faster and Better Drug Discovery?

Artificial intelligence (AI) has become a part of everyday modern life and continues to generate excitement. In this article, we will take a look at how biotechs are advancing into AI-facilitated early drug design, its real-world outcomes so far, and whether it is living up to its potential in the life science industry. AI enables […]

September 28, 2021 - 6 minutesmins - By Alexander Burik

News and Trends 24 Sep 2021

Breath Testing To Be Tapped by UK Pioneer with €50M Fundraising

After years of under-fulfilled promise, breath tests for cancer, liver disease, and respiratory conditions appear to be taking off with UK biotech Owlstone Medical raking in almost €50M (£42M) in an oversubscribed Series D funding round. The round, whose original target was about €43M, was led by the Hong Kong-based Horizons Ventures and was joined […]

September 24, 2021 - 3 minutesmins - By Victor Kotsev

Discovering New Therapeutic Targets for Alzheimer’s Disease

Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is difficult, time-consuming, and expensive, with a high risk of failure. Strategic partnerships can help biotech companies manage costs and access the latest technologies to drive innovation and advance novel therapy ideas. A serious unmet medical need Finding treatments for neurodegenerative […]

September 22, 2021 - 7 minutesmins - By Julia Kaiser

antibiotic resistance investment funding amr

News and Trends 21 Sep 2021

Europe’s Antibiotic Investments Stagnate As Resistance Crisis Looms

Despite the urgent danger of antibiotic resistance, investments into European biotech antibiotic players have remained flat. However, growing regulatory and societal awareness could spell fresh investments in the coming years. Over the last decade, pressure has been mounting on healthcare systems as infectious microbes become harder and harder to fight with antibiotics. Some strains of […]

September 21, 2021 - 7 minutesmins - By Jonathan Smith

Expert Advice 20 Sep 2021

What Makes a Good Chief Financial Officer in the Biotech Industry?

A chief financial officer in the life sciences needs to develop their skills beyond technical expertise. Catherine Moukheibir shares her advice for CFOs in biotech drawing from her experience being one and hiring people for that position. Catherine Moukheibir’s career in biotech spans two decades. She has been a chief financial officer (CFO) twice, and […]

September 20, 2021 - 8 minutesmins - By Victor Kotsev

News and Trends 17 Sep 2021

Cell Therapy Firm Raises €64M to Revolutionize Manufacturing

This week’s €64M Series B fundraise from the French firm TreeFrog Therapeutics is the latest in a thriving movement to make the manufacture of gene and cell therapies easier and cheaper. Cell and gene therapies offer huge potential to treat a wide range of diseases including cancer, neurological, and genetic diseases. They have even shown […]

September 17, 2021 - 8 minutesmins - By Helen Albert

News and Trends 15 Sep 2021

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series A fundraising to potentially treat a myriad of medical conditions by improving gut health. Last week, EnteroBiotix raised €18M (£15.5M) in Series A funding to further develop a pill to restore the patient’s gut microbiome to a healthy state using […]

September 15, 2021 - 4 minutesmins - By Anita Chakraverty

In Depth 15 Sep 2021

Blood Cells: The Future of Drug Delivery

From red blood cells to platelets, the cells in our own blood could prove an effective way of delivering drugs to their target and improving their safety. Many pharmaceutical drugs in the market come with side effects that generally arise from their effects on parts of the body other than their intended target. Even when […]

September 15, 2021 - 7 minutesmins - By Sachin Rawat

News and Trends 10 Sep 2021

The Top European Biotech Funding Rounds in August

UK and German companies led the European biotech funding race in August, specializing in cell therapy, diagnostics, and RNA-based treatments. With summer in full swing, August was a quieter month than July in terms of European biotech funding. Private biotechs in Europe and Israel — in addition to those going public in an initial public […]

September 10, 2021 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

How to Choose the Right Headquarters for Your Biotech Startup

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

Novo Nordisk Foundation Pumps €85M into Carbon Capture Research

Artificial Intelligence: A Road to Faster and Better Drug Discovery?

Breath Testing To Be Tapped by UK Pioneer with €50M Fundraising

Discovering New Therapeutic Targets for Alzheimer’s Disease

Europe’s Antibiotic Investments Stagnate As Resistance Crisis Looms

What Makes a Good Chief Financial Officer in the Biotech Industry?

Cell Therapy Firm Raises €64M to Revolutionize Manufacturing

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

Blood Cells: The Future of Drug Delivery

The Top European Biotech Funding Rounds in August

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!